A Phase 1, SAD and MAD to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral FB-101 in Healthy Adult Male Subjects
Clinical trial NCT07126704 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07126704
- Sponsor
- 1ST Biotherapeutics, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-01
- Primary completion
- 2026-06-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.